2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide-a

DB15243InvestigationalSmall molecule

2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide-a is under investigation in clinical trial NCT01668823 (Photodynamic Therapy in Treating Patients With Lung Cancer).

Formula / weight: C₃₉H₄₈N₄O₄ · 636.837 g/mol (avg)
Also known as: 3-PHORBINEPROPANOIC ACID, 14-ETHYL-9-(1-(HEXYLOXY)ETHYL)-4,8,13,18-TETRAMETHYL-20-OXO-, (3S,4S)- · HPPH · PHOTOCHLOR

Resolves to

Compound

UNIIDOB7Y3RSX0CAS149402-51-7ChEMBLCHEMBL500853

Structure

InChIKeyPVXGCBZIVFCMJK-NMWXTPPCSA-NSMILESCCCCCCOC(C)C1=C2NC(\C=C3/N=C([C@@H](CCC(O)=O)[C@@H]3C)C3=C4N\C(=C/C5=N/C(=C\2)/C(C)=C5CC)C(C)=C4C(=O)C3)=C1C

Transporters

Q9UNQ0ABCG2

What you can answer from here — as of July 08, 2026

1TransporterSubstrate / inhibitor direction, not just membership

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which companies are running trials of 2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide-a, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account